EQS-News: Evotec and TIAP expand LAB150 BRIDGE partnership to include Amgen
businessinsider.com
finance
2022-10-17 13:00:03

Hamburg, Germany, and Toronto, Canada, 17 October, 2022:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Toronto Innovation Acceleration Partners (TIAP) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner. The expansion goes along with a combined investment of US$ 14 m to expedite LAB150 programmes towards the formation of new companies.
LAB150 was created by Evotec and TIAP in 2017 to accelerate Torontos academic research into market-ready products.
